Scientific article
Open access

Targeting the Wnt signalling pathway in cancer: prospects and perils

Published inSwiss Medical Weekly, vol. 149, w20129
Publication date2019

The Wnt pathway, involved in cancer development and progression, has for a long time been said to be undruggable, owing to its complexity and involvement in stem cell biology. This mindset has shifted in the last few years as new research and insights into the pathway mechanisms specific to tumour cells become apparent, leading to the development of multiple compounds targeting the pathway. In this review, we introduce the Wnt pathway and its connections to cancer biology and therapy resistance. We further dive into the details of drugs that have entered clinical trials, examining their successes and side effects. We show that these drugs all have one thing in common: in order to be successful, the drugs must target tumour specific activated sub-branches of the pathway, either at the receptor level or at the nuclear transcription level.

Citation (ISO format)
SHAW, Holly Victoria, KOVAL, Alexey, KATANAEV, Vladimir. Targeting the Wnt signalling pathway in cancer: prospects and perils. In: Swiss Medical Weekly, 2019, vol. 149, p. w20129. doi: 10.4414/smw.2019.20129
Main files (1)
Article (Published version)
ISSN of the journal1424-7860

Technical informations

Creation10/31/2019 12:05:00 PM
First validation10/31/2019 12:05:00 PM
Update time03/15/2023 6:17:18 PM
Status update03/15/2023 6:17:18 PM
Last indexation02/12/2024 1:06:29 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack